Renal Cancer - Results from #1060

Combinatorial biomarker for predicting outcomes to anti-PD-1 therapy in patients with metastatic clear cell renal cell carcinoma. February 24, 2023

Phase II Study Investigating the Safety and Efficacy of Savolitinib and Durvalumab in Metastatic Papillary Renal Cancer (CALYPSO). February 24, 2023

Morbidity and mortality of multivisceral resection with radical nephrectomy for locally advanced renal cell carcinoma: An analysis of the National Surgical Quality Improvement Program (NSQIP) database. February 23, 2023

Fibroblast growth factor receptor type 4 as a potential therapeutic target in clear cell renal cell carcinoma. February 23, 2023

Bioinformatics analysis and experimental validation of cuproptosis-related lncRNA LINC02154 in clear cell renal cell carcinoma. February 22, 2023

Temporary treatment cessation versus continuation of first-line tyrosine kinase inhibitor in patients with advanced clear cell renal cell carcinoma (STAR): an open-label, non-inferiority, randomised, controlled, phase 2/3 trial. February 22, 2023

The association of healthy lifestyle index score and the risk of renal cell cancer in the Netherlands cohort study. February 21, 2023

Cost Effectiveness of Treatment Sequences in Advanced Renal Cell Carcinoma. February 21, 2023

Mitochondrial metabolism in primary and metastatic human kidney cancers. February 21, 2023

Urine supernatant reveals a signature that predicts survival in clear cell renal cell carcinoma. February 20, 2023

Thermal ablation vs. active surveillance for renal masses: a systematic review and network meta-analysis. February 20, 2023

Integrated analysis of the relation to tumor immune microenvironment and predicted value of Stonin1 gene for immune checkpoint blockage and targeted treatment in kidney renal clear cell carcinoma. February 17, 2023

NDUFA4L2 reduces mitochondrial respiration resulting in defective lysosomal trafficking in clear cell renal cell carcinoma. February 17, 2023

Complete Response in Metastatic Clear Cell Renal Cell Carcinoma Patients Treated with Immune-Checkpoint Inhibitors: Remission or Healing? How to Improve Patients' Outcomes? February 16, 2023

Clear Cell Renal Cell Carcinoma: From Biology to Treatment. February 16, 2023

An Update on the Treatment of Papillary Renal Cell Carcinoma. February 16, 2023

Radical Nephrectomy After Immune Checkpoint Inhibitors for Metastatic Renal Cell Carcinoma. February 15, 2023

Real-world outcomes of patients with renal cell carcinoma, surgically treated at regional hospitals, based on a prospective long-term survey of the pre-robotic era. February 15, 2023

Outcomes of Radiofrequency Ablation for Solitary T1a Renal Cell Carcinoma: A 20-Year Tertiary Cancer Center Experience. February 14, 2023

Adjuvant nivolumab plus ipilimumab versus placebo for localised renal cell carcinoma after nephrectomy (CheckMate 914): a double-blind, randomised, phase 3 trial. February 14, 2023

Page 54 of 456